breast cancer
Conditions
Interventions
Molecular Residual Disease,MRD:None
Sponsors
The First Hospital of Jilin University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Before any study-specific procedures, sampling, or analysis, the subject must sign a written informed consent form in accordance with current guidelines and indicate the date. 2. At the time of signing the informed consent form (ICF), the subject must be =18 years old. 3. An Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1. 4. Histologically or cytologically confirmed malignancy of breast.
Exclusion criteria
Exclusion criteria: 1. Subjects with previous malignant tumors other than breast cancer, cervical carcinoma in situ and non-melanoma skin cancer, unless the previous malignant tumors have been diagnosed and definitely treated for at least 5 years, and there is no evidence of subsequent recurrence.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS;OS;The correlation between MRD level and prognosis in patients with low metastasis of breast cancer after local treatment ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life; | — |
Countries
China
Contacts
Public ContactZheng Lv
The First Hospital of Jilin University
Outcome results
None listed